Scleroderma - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Scleroderma > What Your Doctor is Reading About Scleroderma > Review Articles

Review Articles

1. Therapy of childhood generalized morphea: case reports and reviews of the literature of Japanese cases.

Author: Kawashima H; Watanabe C; Kashiwagi Y; Sato S; Ioi H; Sasamoto M; Takekuma K; Ookubo Y; Ooi T; Hoshika A; Kawashima H; Watanabe C; Kashiwagi Y; Sato S; Ioi H; Sasamoto M; Takekuma K; Ookubo Y; Ooi T; Hoshika A;
Institution: Department of Paediatrics, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan. hisashi@tokyo-med.ac.jp
Journal: Pediatr Int. 2006 Jun;48(3):342-5.

2. Systemic sclerosis: a prototypic multisystem fibrotic disorder.

Author: Varga J; Abraham D;
Institution: Devision of Rheumatology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. j-varga@northwestern.edu
Journal: J Clin Invest. 2007 Mar;117(3):557-67.
Abstract URL: Click here to view abstract

3. Skin signs of systemic disease in childhood.

Author: Gilliam AE;
Institution: Department of Dermatology, University of California-San Francisco, 1701 Divisadero St., 3rd Floor, San Francisco, CA 94143-0316, USA. Gilliam@derm.ucsf.edu
Journal: Adv Dermatol. 2006;22:1-30.
Abstract URL: Click here to view abstract

4. Systemic sclerosis: hypothesis-driven treatment strategies.

Author: Charles C; Clements P; Furst DE; Charles C; Clements P; Furst DE; Charles C; Clements P; Furst DE;
Institution: Department of Medicine, Division of Rheumatology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1670, USA.
Journal: Lancet. 2006 May 20;367(9523):1683-91.
Abstract URL: Click here to view abstract

5. Pulmonary-renal syndrome in systemic sclerosis: a report of three cases and review of the literature.

Author: Naniwa T; Banno S; Sugiura Y; Yokota K; Oosawa T; Maeda S; Hayami Y; Takahashi N; Ueda R; Matsumoto Y;
Institution: Division of Rheumatology, Nagoya City University Hospital, Department of Internal Medicine and Molecular Sciences, Nagoya City University Graduate School of Medical Sciences, Kawasumi, Nagoya 467-8601, Japan. tnaniwa@med.nagoya-cu.ac.jp
Journal: Mod Rheumatol. 2007;17(1):37-44. Epub 2007 Feb 20.
Abstract URL: Click here to view abstract

6. Targeting vascular disease in systemic sclerosis.

Author: Kowal-Bielecka O;
Institution: Department of Rheumatology and Internal Medicine, Medical University of Bialystok, Ul. M. Curie-Sklodowskiej 24 A, 15-276 Bialystok, Poland. otylia@amb.edu.pl
Journal: Endocr Metab Immune Disord Drug Targets. 2006 Dec;6(4):401-7.
Abstract URL: Click here to view abstract

7. Targeting fibrosis in systemic sclerosis.

Author: Lafyatis R;
Institution: Rheumatology Section, Boston University School of Medicine, Boston, MA 02118, USA. lafyatis@bu.edu
Journal: Endocr Metab Immune Disord Drug Targets. 2006 Dec;6(4):395-400.
Abstract URL: Click here to view abstract

8. Juvenile systemic sclerosis: report of three cases and review of Japanese published work.

Author: Aoyama K; Nagai Y; Endo Y; Ishikawa O;
Institution: Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan. kumako@ma.neweb.ne.jp
Journal: J Dermatol. 2007 Sep;34(9):658-61.
Abstract URL: Click here to view abstract

9. Interstitial lung disease in systemic sclerosis.

Author: Ostojic P; Cerinic MM; Silver R; Highland K; Damjanov N;
Institution: Institute of Rheumatology, University of Belgrade, Belgrade, Serbia. ostojic@net.yu
Journal: Lung. 2007 Jul-Aug;185(4):211-20.
Abstract URL: Click here to view abstract

10. Depression in patients with systemic sclerosis: a systematic review of the evidence.

Author: Thombs BD; Taillefer SS; Hudson M; Baron M;
Institution: Sir Mortimer B. Davis Jewish General Hospital and McGill University, Montreal, Quebec, Canada. brett.thombs@mcgill.ca
Journal: Arthritis Rheum. 2007 Aug 15;57(6):1089-97.
Abstract URL: Click here to view abstract

11. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.

Author: Proudman SM; Stevens WM; Sahhar J; Celermajer D;
Institution: Rheumatology Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia. sproudman@internode.on.net
Journal: Intern Med J. 2007 Jul;37(7):485-94.
Abstract URL: Click here to view abstract

12. The development of systemic sclerosis classification criteria.

Author: Walker JG; Pope J; Baron M; Leclercq S; Hudson M; Taillefer S; Edworthy SM; Nadashkevich O; Fritzler MJ;
Institution: Faculty of Medicine, University of Calgary, 3330 Hospital Dr NW, T2N 4N1, Calgary, AB, Canada.
Journal: Clin Rheumatol. 2007 Sep;26(9):1401-9. Epub 2007 Feb 7.
Abstract URL: Click here to view abstract

13. Treatment of complications associated with systemic sclerosis.

Author: Moore SC; Desantis ER;
Institution: Robert Wood Johnson University Hospital (RWJUH), New Brunswick, NJ, USA.
Journal: Am J Health Syst Pharm. 2008 Feb 15;65(4):315-21.
Abstract URL: Click here to view abstract

14. Gastric and enteric involvement in progressive systemic sclerosis.

Author: Ebert EC;
Institution: UMDNJ-Robert Wood Johnson Medical School, One Robert Wood Johnson Place, New Brunswick, NJ, USA. ebertec@umdnj.edu
Journal: J Clin Gastroenterol. 2008 Jan;42(1):5-12.
Abstract URL: Click here to view abstract

15. Systemic sclerosis and malignancy: a review of the literature.

Author: Wooten M;
Institution: VA Northern Indiana Healthcare System, Indiana University School of Medicine, Fort Wayne, Indiana 46805, USA. marc.wooten@va.gov
Journal: South Med J. 2008 Jan;101(1):59-62.
Abstract URL: Click here to view abstract

16. Systemic and localized scleroderma.

Author: Chung L; Lin J; Furst DE; Fiorentino D;
Institution: Department of Dermatology, Stanford University School of Medicine, CA 94305, USA.
Journal: Clin Dermatol. 2006 Sep-Oct;24(5):374-92.
Abstract URL: Click here to view abstract

17. Localized and systemic forms of scleroderma in adults and children .

Author: Atzeni F; Bardoni A; Cutolo M; Hunzelmann N; Krieg T; Martini G; Montecucco C; Olski TM; Secchi ME; Valentini G; Zulian F; Sarzi-Puttini P;
Institution: Rheumatology Unit, L Sacco University Hospital, Milan, Italy.
Journal: Clin Exp Rheumatol. 2006 Jan-Feb;24(1 Suppl 40):S36-45.
Abstract URL: Click here to view abstract

18. Treatment of systemic sclerosis.

Author: Allanore Y; Kahan A;
Institution: Rheumatology A Department, Cochin Teaching Hospital, Assistance Publique-Hopitaux de Paris, Paris 5 University, 27, rue du faubourg Saint-Jacques, 75014 Paris, France. yannick.allanore@cch.aphp.fr
Journal: Joint Bone Spine. 2006 Jul;73(4):363-8. Epub 2006 Jan 6.
Abstract URL: Click here to view abstract

19. Systemic and localized scleroderma in children: current and future treatment options.

Author: Rosenkranz ME; Agle LM; Efthimiou P; Lehman TJ;
Institution: Hospital for Special Surgery, Division of Pediatric Rheumatology, New York, New York, USA.
Journal: Paediatr Drugs. 2006;8(2):85-97.
Abstract URL: Click here to view abstract

20. Bosentan: a review of its use in pulmonary arterial hypertension and systemic sclerosis.

Author: Oldfield V; Lyseng-Williamson KA;
Institution: Adis International Inc., Yardley, Pennsylvania 19067, USA. demail@adis.com
Journal: Am J Cardiovasc Drugs. 2006;6(3):189-208.
Abstract URL: Click here to view abstract

21. Prognostic markers for systemic sclerosis.

Author: Meyer O;
Institution: Assistance publique-Hopitaux de Paris, hopital Bichat, 46, rue Henri-Huchard, 75018 Paris, France. olivier.meyer@bch.aphp.fr
Journal: Joint Bone Spine. 2006 Oct;73(5):490-4. Epub 2006 Jun 2.
Abstract URL: Click here to view abstract

22. Mechanisms and consequences of fibrosis in systemic sclerosis.

Author: Denton CP; Black CM; Abraham DJ;
Institution: Centre for Rheumatology, Royal Free and University College Medical School, London, and Royal Free Hospital, UK. c.denton@medsch.ucl.ac.uk
Journal: Nat Clin Pract Rheumatol. 2006 Mar;2(3):134-44.
Abstract URL: Click here to view abstract

23. Autoimmune connective tissue disease: scleroderma.

Author: Wilson H; Vincent R;
Institution: Centre for Rheumatology, Royal Free Hospital, London.
Journal: Br J Nurs. 2006 Aug 10-Sep 13;15(15):805-9.
Abstract URL: Click here to view abstract

24. New therapeutic strategies in the management of systemic sclerosis.

Author: Allanore Y; Avouac J; Wipff J; Kahan A;
Institution: Rene Descartes University, Medical Faculty, Department of Rheumatology A, Cochin Hospital, Paris, France. yannick.allanore@cch.aphp.fr
Journal: Expert Opin Pharmacother. 2007 Apr;8(5):607-15.
Abstract URL: Click here to view abstract

25. New therapeutic strategies for systemic sclerosis--a critical analysis of the literature.

Author: Zandman-Goddard G; Tweezer-Zaks N; Shoenfeld Y;
Institution: Department of Medicine B and Center for Autoimmune Diseases, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel.
Journal: Clin Dev Immunol. 2005 Sep;12(3):165-73.
Abstract URL: Click here to view abstract

26. Surgical treatment of destructive calcific lesions of the cervical spine in scleroderma: case series and review of the literature.

Author: Smucker JD; Heller JG; Bohlman HH; Whitesides TE Jr; Smucker JD; Heller JG; Bohlman HH; Whitesides TE Jr;
Institution: Department of Orthopaedic Surgery, The University of Iowa, Iowa City, IA 52242, USA. joseph-smucker@uiowa.edu
Journal: Spine. 2006 Aug 1;31(17):2002-8.
Abstract URL: Click here to view abstract

27. Targeted therapy for systemic sclerosis.

Author: Steen V; Steen V;
Institution: Medstar Georgetown University, Division of Rheumatology, Immunology, and Allergy, 3800 Reservoir Road NW, LL Gorman, Washington, DC 20007, USA. steenv@georgetown.edu
Journal: Autoimmun Rev. 2006 Feb;5(2):122-4. Epub 2005 Sep 21.
Abstract URL: Click here to view abstract

28. Digital ulcers in patients with systemic sclerosis.

Author: Chung L; Fiorentino D; Chung L; Fiorentino D;
Institution: Stanford University School of Medicine, Department of Immunology and Rheumatology, 1000 Welch Road, Suite #203, Stanford, CA 94305, USA. shauwei@stanford.edu
Journal: Autoimmun Rev. 2006 Feb;5(2):125-8. Epub 2005 Sep 13.
Abstract URL: Click here to view abstract

29. The spectrum of scleroderma lung disease.

Author: Highland KB; Garin MC; Brown KK;
Institution: Division of Pulmonary Critical Care, Allergy, and Sleep Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA. highlakb@musc.edu
Journal: Semin Respir Crit Care Med. 2007 Aug;28(4):418-29.
Abstract URL: Click here to view abstract

30. Small cell lung cancer associated with systemic sclerosis.

Author: Kanaji, Nobuhiro; Fujita, Jiro; Bandoh, Shuji; Fukumoto, Tetsuya; Ishikawa, Masashi; Haba, Reiji; Ishii, Tomoya; Kubo, Akihito; Ishida, Toshihiko;
Institution: First Department of Internal Medicine, faculty of Medicine, Kagawa University, Kagawa.
Journal: Intern Med 2005 Apr;44(4):315-8.
Abstract URL: Click here to view abstract

31. Scleroderma in children.

Author: Zulian, Francesco;
Institution: Pediatric Rheumatology Unit, Department of Pediatrics, University of Padova, Via Giustiniani 3 35128, Padua, Italy. zulian@pediatria.unipd.it
Journal: Pediatr Clin North Am 2005 Apr;52(2):521-45, vii.
Abstract URL: Click here to view abstract

32. Clinical aspects of lung involvement: lessons from idiopathic pulmonary fibrosis and the scleroderma lung study.

Author: Highland, Kristin B; Silver, Richard M;
Institution: Division of Rheumatology and Immunology, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 912 CSB, Charleston, SC 29425, USA.
Journal: Curr Rheumatol Rep 2005 Apr;7(2):135-41.
Abstract URL: Click here to view abstract